NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Idera Pharmaceuticals Inc (NASDAQ: IDRA)

 
IDRA Technical Analysis
5
As on 18th Jan 2023 IDRA STOCK Price closed @ 8.64 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.69 & Strong Buy for SHORT-TERM with Stoploss of 1.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IDRASTOCK Price

Open 12.75 Change Price %
High 16.00 1 Day 8.21 1909.30
Low 8.64 1 Week 7.93 1116.90
Close 8.64 1 Month 8.31 2518.18
Volume 1126300 1 Year 7.59 722.86
52 Week High 1.11 | 52 Week Low 0.23
 
NASDAQ USA Most Active Stocks
TSLA 244.40 %
TTOO 0.07 %
SOFI 8.18 %
FFIE 0.33 %
PONO 1.72 2.38%
AMD 124.92 %
IDEX 0.06 %
NKLA 0.70 %
AMZN 123.43 %
AAPL 180.96 %
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
SBEAW 2.05 51.85%
BRPMW 0.94 46.88%
BSGAU 11.29 41.12%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
MILEW 0.06 -53.85%
BTAQW 0.01 -50.00%
ALACW 0.01 -50.00%
ALF 0.01 -50.00%
ALF 0.01 -50.00%
LOTZW 0.01 -50.00%
IGNY 6.98 -46.51%
IGNYW 0.17 -45.16%
 
 
IDRA
Daily Charts
IDRA
Intraday Charts
Whats New @
Bazaartrend
IDRA
Free Analysis
 
IDRA Important Levels Intraday
RESISTANCE22.82
RESISTANCE18.27
RESISTANCE15.46
RESISTANCE12.65
SUPPORT4.63
SUPPORT1.82
SUPPORT-0.99
SUPPORT-5.54
 
IDRA Forecast December 2023
4th UP Forecast9.12
3rd UP Forecast8.97
2nd UP Forecast8.87
1st UP Forecast8.78
1st DOWN Forecast8.5
2nd DOWN Forecast8.41
3rd DOWN Forecast8.31
4th DOWN Forecast8.16
 
IDRA Weekly Forecast
4th UP Forecast8.85
3rd UP Forecast8.78
2nd UP Forecast8.74
1st UP Forecast8.70
1st DOWN Forecast8.58
2nd DOWN Forecast8.54
3rd DOWN Forecast8.50
4th DOWN Forecast8.43
 
IDRA Forecast2023
4th UP Forecast39.05
3rd UP Forecast29.3
2nd UP Forecast23.27
1st UP Forecast17.24
1st DOWN Forecast0.04
2nd DOWN Forecast-5.99
3rd DOWN Forecast-12.02
4th DOWN Forecast-21.77
 
 
IDRA Other Details
Segment EQ
Market Capital 45406976.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IDRA Address
IDRA
 
IDRA Latest News
 
Your Comments and Response on Idera Pharmaceuticals Inc
 
IDRA Business Profile
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania. Address: 505 Eagleview Boulevard, Exton, PA, United States, 19341
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service